Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH-antagonist in Medicated FET Cycles
NCT03763786Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetrorelix in infertility, sponsored by University of Oxford. Status: unknown.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03763786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763786.